Motor nerve terminal outgrowth (NTO) at neuromuscular junctions (NMJs) occurs rapidly in response to denervation changes in muscle. We have previously found that NT0 can produce an elongation of the synaptic area of the NMJ as defined by cholinesterase-silver staining.
In the present study, we examined the effects of NT0 on a postsynaptic muscle membrane component, the usually stable cluster of acetylcholine receptors (AChRs) at the NMJ. NT0 was evoked in rat soleus muscles using botulinum toxin. AChRs were demonstrated using immunocytochemistry or autoradiography of cu-bungarotoxin binding. Our results show that NT0 induces rapid elongation of the cluster of AChRs at the NMJ within 7 d of treatment with botulinum toxin. The growth in the size of the AChR clusters was accompanied by an increase in the number of AChRs/NMJ.
No elongation of AChR clusters was seen following surgical denervation, suggesting that cluster growth is related to NT0 and not to denervation changes in muscle per se. Growth of NMJ-AChR clusters appeared to result primarily from 2 processes: insertion of new AChRs into the NMJ membrane and, surprisingly, redistribution of preexisting NMJ-AChRs. These results show that NT0 can cause rapid changes in the normally stable cluster of AChRs at the NMJ. Motor nerve terminals provide a strong and anatomically precise control of AChRs at the NMJ.
The distribution and turnover of acetylcholine receptors (AChRs) in skeletal muscle membrane are regulated to a large extent by motor nerves. During development, AChRs cluster at the site of contact between the motor nerve terminal and the muscle membrane Bevan and Steinbach, 1977; Burden 1977; Braithwaite and Harris 1979; Frank and Fischbach, 1979) . In innervated adult muscles, AChRs are localized almost exclusively at neuromuscular junctions (NMJs) (Miledi, 1960; Fambrough and Hartzell, 1972; Fertuck and Salpeter, 1976; Fambrough, 1979) . The nerve induces considerable stability in these clusters ofjunctional AChRs, Received May 23, 1986; revised Oct. 13, 1986; accepted Jan. 8, 1987. This work was supported by Grants PO1 NS19020 and 5ROl HD048 17 from the National Institutes of Health, and U. (Berg and Hall, 1975; Chang and Huang, 1975; Axelrod et al., 1979; Fambrough, 1979; Levitt and Salpeter, 198 1; Young and Poo, 1983; Stya and Axelrod, 1984) . In the course of recent studies of synaptic plasticity, we have found that outgrowth from motor nerve terminals can induce rapid modifications in previously stable structures at the NMJ (Pestronk et al., 1976; Drachman 1978b, 1985a) . During the process of nerve terminal outgrowth (NTO) (e.g., after botulinum treatment), the area of synaptic contact between motor nerve terminals and muscle fibers becomes elongated over periods as short as 5-7 d. We have shown that this change is accompanied by an increase in the length of the patch of cholinesterase at the NMJ (Pestronk and Drachman, 197813) . In the present experiments we asked whether the cluster of postsynaptic AChRs in the muscle membrane undergoes a similar "plastic" change in its distribution, and how this change occurs. Our results provide information about the mechanisms of postjunctional adaptation occurring during periods of synaptic remodeling in the adult animal in vivo. They suggest that the growing nerve terminal can induce a considerable degree of plasticity in normally stable, postsynaptic AChR clusters. (Stanley and Drachman, 1983) . To study the behavior, during NTO, of preexisting "stable" junctional AChRs, i.e., those with a long half-life, we labeled AChRs with oc-BTx 3 d before the administration of botulinum toxin. Using this procedure a-BTx labeling of AChRs occurs within the 6-l 2 hr after injection (Stanley and Drachman, 1983 (Stanley and Drachman, 1983) . Thus, at the onset of NTO, virtually all of the a-BTx-labeled AChRs at the NMJ are stable. Optimally, in the study of prelabeled AChRs, the initial injection of labeled a-BTx (to bind and identify preexisting AChRs) would be followed by perfusion of unlabeled a-BTx to prevent rebinding of the original labeled toxin to other AChRs. Unfortunately, this pro-tocol was impossible in these experiments because continuous a-BTx blockade prevents the NT0 phenomenon under study Drachman 1978b, 1985a) . However, previous data from our laboratory and others shows that ol-BTx does not dissociate from AChRs or rebind to other AChRs to any significant degree (Heinemann et al., 1978; Stanley and Drachman, 1983 Immunocytochemical staining of AChRs. Soleus muscles were removed, pinned at resting length, and frozen in isopentane cooled with solid CO,. The muscles were sectioned longitudinally (50 Frn thickness) in a cryostat. After the sections were air-dried, endogenous peroxidases were removed by incubation with 0.3% H,O, in PBS for 30 min. After this and each subsequent step, sections were washed in PBS. Each antiserum was diluted in PBS with 1% normal goat serum (NGS). To stain a-BTx-labeled AChRs, sections were (1) covered with a 5% solution of NGS in PBS for 30 min, drained, and covered for 1 hr with rabbit antioc-BTx antiserum (1:200); (2) incubated with goat anti-rabbit IgG antiserum (1:20); (3) treated for 1 hr with rabbit peroxidase-antiperoxidase (PAP) (1:40); (4) rinsed in 0.05 M Tris buffer, pH 7.3, and developed for peroxidase in the Tris buffer using diaminobenzidine (DAB) as the substrate (Stemberger, 1979) . Using this technique, the distribution of junctional AChRs was clearly delineated even in muscles with significant levels of extrajunctional AChRs.
Staining of cholinesterase. In some sections the junctional AChRs and cholinesterase were visualized simultaneously to provide a direct comparison of the distributions of the 2 endplate molecules. In this case, prior to incubation with H,O,, sections were stained using a bromoindoxylacetate method (Pestronk and Drachman, 1978a) , which gives a blue color contrasting with the brown peroxidase-stained AChRs.
Measurement of junctional AChR cluster length. Stained slides were coded and examined "blind," the microscopist having no knowledge of the experiment treatment performed on the muscle. The length of each junction, as outlined by the brown peroxidase stain for AChRs or the blue stain for cholinesterase, was measured parallel to the length of the fiber. This measurement was reliable and reproducible. Similar results were found when repeated counts were made by the same or different examiners.
We used autoradiography to quantitate the distribution of newly inserted junctional AChRs. Blockade of existing junctional AChRs with unlabeled cu-BTx was performed 6 d after treatment with botulinum toxin. One day later, 30 ~1 of 12SI-a-BTx (20 &ml) was injected into the same soleus muscle. In some cases (when muscles were to be removed 24 hr later), an injection of 20 Kg of unlabeled ol-BTx was given 2-3 hr after the 12SI-ol-BTx to prevent further labeling. At 2-24 hr after 1*51-cu-BTx labeling, muscles were removed, frozen, and sectioned longitudinally (40 PM) in a cryostat. Sections were washed, stained for cholinesterase using the bromoindoxylacetate method, and processed for autoradiography using Kodak NTB-2 emulsion.
To quantitate the distribution of newly inserted AChRs at elongated NMJs, we compared the density of silver grains at the center and ends of endplates. Endplates were selected for analysis if they were stained enface and were probably elongated (62.5 pm or longer in length). Counts of grains were made in 12.5 pm lengths at the ends and around the center of the cholinesterase-stained endplate. Background grain density, determined on emulsion outside the fibers, was subtracted from all values determined over the fibers.
Statistical methods. Results are expressed as means + SE. The significance of the differences between experimental groups was calculated by Student's 2-tailed t-test.
Results
Changes in the junctional AChR cluster during terminal sprouting As in our previous studies, there was a significant amount of nerve terminal outgrowth in rat soleus muscles 7 d after treatment with botulinum toxin. During this period the nerve terminal arborization became more branched and the patch of junctional cholinesterase elongated. Our results showed that the iunctional AChR clusters also became elongated (Fig. 1, a, b ) during the period of NTO. One week after botulin& treatment, junctional AChR clusters in the soleus muscle measured 5 1 * 1 pm in length, significantly (p < 0.01) greater than the 39 f 0.5 wrn cluster length in controls (Table 1 ). In contrast, there was no change in-cluster length (39 t-0.8 pm) a week after surgical denervation of the muscle. The mean lengths of junctional AChR clusters and cholinesterase-stained endplates were similar, both in control muscles and in those treated with botulinum. At individual NMJs the distributions of AChRs and of cholinesterase were virtually identical, with colocalization of the 2 molecules both at control NMJs and at elongated NMJs from muscles treated with botulinum toxin. Elongation of the junctional AChR cluster was accompanied by an increase in the number of AChRs in the cluster. After NT0 there were 5.5 -t 0.3 x 10' AChRs/NMJ compared with 3.4 ~fr 0.4 x 10' AChRs/ NMJ (p < 0.001) in control soleus muscles, a 62% increase.
Quantitation of junctional AChRs. Junctional AChRs were labeled and measured using an 1*51-a-BTx binding method, as previously described (Berg et al., 1972; Pestronk and Drachman, 1985b) . To measure AChRs at elongated junctions, rat soleus muscles were removed and incubated with 12SI-a-BTx at 3 months after treatment with botulinum toxin. The 3 month period was chosen to allow an accurate quantitative determination of AChRs/NMJ. At this time the number of extrajunctional AChRs has returned to background levels. At earlier times after botulinum treatment, high levels of extrajunctional AChRs make measurement of AChRs/NMJ difficult.
Distribution of newly inserted junctional AChRs. In these experiments, following botulinurn treatment; existing AChRs were blocked using unlabeled a-BTx (20 ul oc-BTx in 100 u&ml in Ringer) iniected directlv into the soleus muscle. The newly ins&ted junctional AChRs were studied from 1 to 6 d later.
In some muscles. an avidin-biotin immunocvtochemical techniaue (Hsu et al., 198 la, b ) was used to demonstrate newly inserted AChRs at NMJs. Blockade of existing AChRs was performed 1 d after botulinum treatment and muscles removed 6 d later. Longitudinal cryostat sections, 40 pm thick, were air-dried, washed in PBS, and lightly fixed with 1% formaldehyde in PBS for 5 min. After this and each subsequent step, sections were washed in PBS. The sections were sequentially incubated in (1) 0.1% phenylhydrazine in PBS for 1 hr at 37°C to inhibit endogenous peroxidases; (2) custom biotinylated a-BTx (Vector Laboratory) at a 1:50 dilution in PBS with 0.1% BSA for 1 hr; (3) cell sortergrade fluorescent-tagged avidin (Vector Laboratory) at a 1:200 dilution in PBS with 0.1% BSA for 1 hr; (4) 5% NGS in PBS for 15 min followed by biotinylated goat anti-avidin IgG, 1:200 in PBS with 1% NGS for 1 hr; and (5) avidin-biotin-peroxidase complex (Vector Laboratory) for 1 hr. After washing in PBS and rinsing in 0.05 M Tris buffer, the sections were developed for peroxidase using DAB as the substrate. Cobalt chloride, l%, was added to the DAB solution to help enhance specific staining and reduce background staining (Hsu and Soban, 1982) . With immunohistochemistry, the high-density AChR clusters at NMJs were clearly delineated, even in muscles with extrajunctional AChRs.
Mechanisms underlying the growth of the junctional AChR cluster New junctional AChRs. We first examined whether AChRs that were newly synthesized and inserted in the muscle membrane play a role in the elongation of the junctional AChR cluster. New AChRs were studied by blocking preexisting AChRs with oc-BTx, waiting 24 hr to 6 d for new AChRs to be inserted into the membrane, and then selectively labeling the new AChRs with lZ51-o-BTx or biotin-ol-BTx.
Our results showed that in botulinum-treated muscles new AChRs were present over the entire length ofelongated NMJs. The distribution ofnew AChRs at NMJs was simila; to that of the total population ofjunctional AChRs and to the pattern of cholinesterase at both normal and elongated NMJs (Fig. 2, a, b) . The intensity of staining of new junctional AChRs was relatively uniform over the NMJ; there Redistribution of junctional AChRs. We next studied the behavior of preexisting junctional AChRs during growth of the NMJ (Fig. 3, a, b ). AChRs were labeled in vivo by injecting L~-BTx into the soleus muscle 3 d before botulinurn treatment. Seven days after botulinurn treatment the distribution of the remaining ol-BTx-labeled AChRs was compared to the total population of AChRs at NMJs in botulinum-treated and control muscles. Our results showed that the distribution of the preexisting stable junctional AChRs changed during growth of the NMJ. The average length of clusters of preexisting junctional AChRs was 53 + 2 pm at 7 d after botulinurn treatment, significantly (p < 0.01) greater than the 44 f 1 pm for controls. Histograms also demonstrated the increase in the length of preexisting junctional AChR clusters after NT0 (Fig. 4) . At individual endplates the distribution of preexisting AChRs mirrored that of cholinesterase even at the most elongated NMJs.
Migration of extrajunctional AChRs. In a final set of experiments we examined whether migrating extrajunctional AChRs contribute to the elongated junctional AChR cluster. In developing muscle fibers this phenomenon has been documented by labeling extrajunctional AChRs and finding them to be concentrated at NMJs, especially around their periphery, l-3 d later Weinberg et al., 1981; Stya and Axelrod, 1983; Ziskind-Conhaim et al., 1984; Role et al., 1985) . In the present studies we blocked preexisting AChRs in the soleus muscle 6 d after treatment with botulinurn toxin. The AChRs that accumulated in the membrane during the next 24 hr were then labeled with 1251-a-BT~. Two hours afterward an injection of 40-fold more a-BTx was injected to inhibit further lz51-ol-BTx labeling of AChRs. Two and 24 hours after labeling with L251-a-BT~, we measured the pattern of labeled AChRs at the NMJ. Our data showed that at both time points labeled AChRs were distributed evenly over the length of the NMJ (Table 2 ). There was no evidence of accumulation of labeled AChRs at the periphery of the NMJ. Grain density at NMJs decreased by 13% over the 22 hr period. 
Discussion Association of NT0 with AChR cluster elongation
In the normal adult animal the cluster of postsynaptic junctional AChRs is remarkably stable. :The turnover of most of these AChRs is slow (Berg and Hall, 1975; Chang and Huang, 1975; Fambrough, 1979; Levitt and Salpeter, 198 l) , they have limited mobility within the muscle membrane (Fambrough and Pagano, 1977; Axelrod et al., 1979; Salpeter and Harris, 1983) , and their total number persists relatively unchanged throughout the life of the animal (Pestronk et al., 1980) . In the present study we have found that NT0 can induce rapid modifications in this normally stable junctional AChR cluster. During such periods of synaptic plasticity (i.e., NTO), the junctional AChR cluster undergoes distinct changes, becoming elongated and accumulating increased numbers of AChRs. The change in the distribution of junctional AChRs during NT0 parallels the remodeling of other synaptic elements. Quantitatively, the increase in the mean length of the junctional AChR cluster is similar to that of the cholinesterase stained at the NMJ. At individual NMJs, both in normals and after NTO, the pattern of the junctional AChR cluster in muscle membrane is virtually AChRs inserted between days 6 and 7 after botulinum treatment were labeled in vivo with 1251-(u-BT~ and muscles removed 2 hr later. Endplates are also lightly stained for cholinesterase. Note the even distribution of silver grains at NMJs. Bar, 40 pm. b, NMJ stained for new AChRs appearing after botulinurn treatment, using immunocytochemistry. The staining is uniformly distributed over the length of the NMJ. Bar, 25 pm.
identical to that of cholinesterase in the basal lamina, which, in turn, mirrors the distribution of the presynaptic nerve terminal arborization. The close anatomic correspondence between junctional AChRs, cholinesterase, and nerve terminals, even during periods of the modification of the NMJ, suggests the existence of precise interactions among these synaptic elements.
Mechanisms of AChR cluster growth
In the present experiments we have studied synaptic plasticity at NMJs treated with botulinum toxin. Botulinum treatment blocks neuromuscular transmission (Brooks, 1954; Kao et al., 1976; Simpson, 198 1) resulting in denervation-like changes in muscle which, in turn, stimulate NT0 (Duchen and S&itch, 1968; Brown et al., 198 1; Pestronk and Drachman, 1985a) . One could postulate that the change in the junctional AChR cluster occurring after botulinum treatment is either (1) a direct byproduct of denervation changes in muscle such as fiber atrophy or an increase in extrajunctional AChRs or (2) induced by NTO. However, the former possibility seems unlikely. After nerve section, a procedure that produces more denervation changes in muscle than botulinum treatment (Mathers and Thesleff, 1978; Drachman et al., 198_2) , there is no growth of the junctional AChR cluster. It thus seems probable that the growth in the junctional AChR cluster seen in the present experiments requires the anatomical integrity of the nerve and is secondary to the process of NTO.
The NTO-induced growth of junctional AChR clusters could occur by several mechanisms, including (1) insertion of newly synthesized AChRs into the membrane at the NMJ, either focally to form new areas of AChR clustering or generally over the whole length of the longer postsynaptic membrane; (2) mi- The uniformity of distribution of newly inserted AChRs at elongated NMJs was examined by comparing the density of AChRs in central and peripheral endplate segments. Existing AChRs in soleus muscles were blocked with unlabeled a-BTx at 6 d after botulinum treatment. One day later, new AChRs were labeled in viva with i2~I-~-BT~. Muscles were removed 2 and 24 hr after labeling and autoradiograms obtained of longitudinal frozen sections. At each NMJ, silver grains were counted over 12.5 Mm lengths at the ends and 25 rrn lengths at the centers of the NMJ. Counts are expressed as number of silver grains per micron of NMJ length. Note that the distribution of grains is even. There is no significant difference at either time point between the density of labeled AChRs at the ends and centers of the NMJ. AChRs, newly inserted at enlarging NMJs in botulinum-treated muscles, could derive either from the population of newly synthesized AChRs or from extrajunctional AChRs migrating to the NMJ. In developing muscle fibers, preexisting extrajunctional AChRs can migrate in the membrane to form a cluster at the site of a new nerve-muscle contact Stya and Axelrod, 1983; Ziskind-Conhaim et al., 1984; Role et al., 1985) . Migration of extrajunctional AChRs may also contribute to endplates forming in ectopically innervated muscle (Weinberg et al., 1981) . At preformed NMJs in adult muscle one would expect such migrating AChRs to accumulate preferentially around the periphery of the NMJ. However, in the present experiments new AChRs accumulated uniformly over the length ofelongated NMJs. There was no evidence of selective localization of new junctional AChRs at the periphery of NMJs. This suggests that, if migration of extrajunctional AChRs to the NMJs occurs, it provides only a minority of the new junctional AChRs. In any case, at later times (e.g., 3 months after botulinum treatment), when extrajunctional AChRs have virtually disappeared, redistributed receptors cannot provide the increased supply of AChRs at elongated NMJs.
A final source of AChRs at elongated NMJs could be redistribution of preexisting NMJ AChRs. At first consideration this possibility seems unlikely because, as noted above, junctional AChRs have been thought to be very stable. However, our data show that NT0 can induce significant movement in the previously stable AChRs. After NTO-induced elongation of the during NMJ elongation.
NMJ, the preexisting stable junctional AChRs are redistributed over the entire new length of the NMJ. This suggests that NT0 can precisely direct the movement of AChRs over distances of up to 15-30 pm in the skeletal muscle membrane. The exact pattern of receptor movement is unclear. Possibilities include migration of individual AChR molecules, movement or elongation of some of the subdivisions of AChRs that are often found at mammalian NMJs (Figs. 1, 3 ) (Salpeter and Harris, 1983) or reorganization of the entire NMJ.
In conclusion, the present study provides further documentation of the remarkable and complex bidirectional trophic interactions between motor nerves and muscle AChRs. In adult muscles, with normal synaptic transmission, AChRs in muscle are localized at its site of contact with the motor nerve. When synaptic transmission from nerve to muscle is interrupted, new AChRs appear all along the muscle membrane. These muscle AChRs have a reverse trophic influence, inducing outgrowth from the presynaptic nerve terminals Drachman, 1978b, 1985a) . We have now found that the muscle-induced outgrowth of presynaptic nerve terminals, in turn, causes elongation of the AChR cluster at the NMJ. Our data suggest that mechanisms in skeletal muscle underlying this plasticity of the postsynaptic membrane include redistribution of preexisting AChRs and synthesis of new AChRs. Further studies are required to understand the trophic influence from nerve that can induce such anatomically precise changes in a previously stable postsynaptic membrane.
